T1	CHEM 46 56	Vitamina D
#1	AnnotatorNotes T1	C0042866; vitamin D; Hormone · Pharmacologic Substance · Vitamin
T2	PROC 62 83	tratamiento adyuvante
#2	AnnotatorNotes T2	C0677850; Adjuvant therapy; Therapeutic or Preventive Procedure
T3	DISO 92 132	esclerosis múltiple recurrente remitente
#3	AnnotatorNotes T3	C0751967; Multiple Sclerosis, Relapsing-Remitting; Disease or Syndrome
T4	PROC 134 204	estudio unicéntrico, aleatorizado, doble ciego, controlado por placebo
T5	PROC 333 357	consentimiento informado
#4	AnnotatorNotes T5	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T6	DISO 228 268	ESCLEROSIS MULTIPLE RECURRENTE REMITENTE
T7	PROC 407 421	Diagnosticados
#5	AnnotatorNotes T7	C0011900; Diagnosis; Diagnostic Procedure
T8	DISO 425 465	esclerosis múltiple recurrente-remitente
T9	DISO 541 551	enfermedad
#6	AnnotatorNotes T9	C0012634; Disease; Disease or Syndrome
T10	PROC 569 593	tratamiento con fármacos
#7	AnnotatorNotes T10	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure
T11	PROC 619 630	tratamiento
#8	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	CHEM 953 967	inmunosupresor
#9	AnnotatorNotes T12	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T13	CHEM 641 656	interferón beta
#10	AnnotatorNotes T13	C0751599; Recombinant Interferon Beta; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T14	CHEM 659 681	acetato de glatiramero
#11	AnnotatorNotes T14	C0289884; glatiramer acetate; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T15	PROC 818 841	medidas anticonceptivas
T16	DISO 902 909	alergia
#12	AnnotatorNotes T16	C1527304; Allergic Reaction; Pathologic Function
T17	CHEM 915 925	vitamina D
#13	AnnotatorNotes T17	C0042866; vitamin D; Hormone · Pharmacologic Substance · Vitamin
T18	PROC 941 967	tratamiento inmunosupresor
#14	AnnotatorNotes T18	C0021079; Therapeutic immunosuppression; Therapeutic or Preventive Procedure
T19	DISO 976 995	esclerosis múltiple
#15	AnnotatorNotes T19	C0026769; Multiple Sclerosis; Disease or Syndrome
T20	DISO 998 1011	Hipercalcemia
#16	AnnotatorNotes T20	C0020437; Hypercalcemia; Disease or Syndrome
T21	DISO 1014 1033	Hiperparatiroidismo
#17	AnnotatorNotes T21	C0020502; Hyperparathyroidism; Disease or Syndrome
T22	DISO 1048 1075	enfermedad renal o hepática
T23	ANAT 1067 1075	hepática
#18	AnnotatorNotes T23	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T24	PROC 1081 1095	valores de ALS
T25	CHEM 1092 1095	ALS
T26	PROC 1155 1179	Tratamiento concomitante
#19	AnnotatorNotes T26	C1707479; Concomitant Therapy; Therapeutic or Preventive Procedure
T27	CHEM 1209 1226	hidroclorotiazida
#20	AnnotatorNotes T27	C0020261; hydrochlorothiazide; Organic Chemical · Pharmacologic Substance
T28	CHEM 1228 1240	clorotiazida
#21	AnnotatorNotes T28	C0008273; chlorothiazide; Organic Chemical · Pharmacologic Substance
T29	CHEM 1242 1254	clortalidona
#22	AnnotatorNotes T29	C0008294; chlorthalidone; Organic Chemical · Pharmacologic Substance
T30	CHEM 1256 1266	indapamida
#23	AnnotatorNotes T30	C0021186; indapamide; Organic Chemical · Pharmacologic Substance
T31	CHEM 1269 1279	metolazona
#24	AnnotatorNotes T31	C0025854; metolazone; Organic Chemical · Pharmacologic Substance
T32	CHEM 1282 1306	fármacos antiepilépticos
T33	CHEM 1308 1321	colestiramina
#25	AnnotatorNotes T33	C0008402; cholestyramine resin; Organic Chemical · Pharmacologic Substance
T34	CHEM 1324 1334	colestipol
#26	AnnotatorNotes T34	C0009279; colestipol; Organic Chemical · Pharmacologic Substance
T35	DISO 1339 1354	Depresión mayor
#27	AnnotatorNotes T35	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T36	DISO 1358 1380	Hiper o hipotiroidismo
T37	DISO 1383 1402	Enfermedad cardíaca
T38	ANAT 1394 1402	cardíaca
#28	AnnotatorNotes T38	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T39	DISO 1404 1412	arritmia
#29	AnnotatorNotes T39	C0003811; Cardiac Arrhythmia; Disease or Syndrome
T40	DISO 1415 1424	Epilepsia
#30	AnnotatorNotes T40	C0014544; Epilepsy; Disease or Syndrome
T41	PROC 1435 1446	tratamiento
#31	AnnotatorNotes T41	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T42	CHEM 1451 1475	fármacos antiepilépticos
T43	DISO 1490 1515	abuso enólico o de drogas
T44	CHEM 585 593	fármacos
#32	AnnotatorNotes T44	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T45	DISO 637 639	EM
#33	AnnotatorNotes T45	C0026769; Multiple Sclerosis; Disease or Syndrome
T46	ANAT 1059 1064	renal
#34	AnnotatorNotes T46	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T47	PROC 1098 1101	AST
#35	AnnotatorNotes T47	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T48	CHEM 1184 1195	digitálicos
#36	AnnotatorNotes T48	C0304520; Digitalis preparation; Organic Chemical · Pharmacologic Substance
T49	CHEM 1197 1207	diuréticos
#37	AnnotatorNotes T49	C0012798; Diuretics; Pharmacologic Substance
T50	Date 13 17	2012
T51	LIVB 297 306	Pacientes
#38	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	LIVB 360 369	Pacientes
#39	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T53	Age 373 391	entre 18 y 65 años
T54	LIVB 556 565	Pacientes
#40	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	Duration 691 707	al menos 6 meses
T56	LIVB 767 789	mujeres en edad fértil
#41	AnnotatorNotes T56	C4324275; Woman of childbearing potential; Population Group
T58	LIVB 928 937	Pacientes
#42	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T59	PHYS 1132 1140	Embarazo
#43	AnnotatorNotes T59	C0032961; Pregnancy; Organism Function
T60	PHYS 1143 1152	lactancia
#44	AnnotatorNotes T60	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T63	Age 778 789	edad fértil
T57	CHEM 1509 1515	drogas
#45	AnnotatorNotes T57	C0086190; Illicit Drugs; Hazardous or Poisonous Substance
A1	Population_data T56 Age
A2	Status T16 History_of
A3	Status T22 History_of
A4	Status T43 History_of
#46	AnnotatorNotes T6	C0751967; Multiple Sclerosis, Relapsing-Remitting; Disease or Syndrome
#47	AnnotatorNotes T8	C0751967; Multiple Sclerosis, Relapsing-Remitting; Disease or Syndrome
#48	AnnotatorNotes T15	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
#49	AnnotatorNotes T22	C0022658; Kidney Diseases; Disease or Syndrome + C0023895; Liver diseases; Disease or Syndrome
#50	AnnotatorNotes T32	C3537002; Anti-epileptic Agent [EPC]; Pharmacologic Substance
#51	AnnotatorNotes T36	C0020550; Hyperthyroidism; Disease or Syndrome + C0020676; Hypothyroidism; Disease or Syndrome
#52	AnnotatorNotes T37	C0018799; Heart Diseases; Disease or Syndrome 
#53	AnnotatorNotes T42	C3537002; Anti-epileptic Agent [EPC]; Pharmacologic Substance
#54	AnnotatorNotes T43	C0085762; Alcohol abuse; Mental or Behavioral Dysfunction + C0013146; Drug abuse; Mental or Behavioral Dysfunction 
T61	Food 1496 1503	enólico
#55	AnnotatorNotes T61	C0001967; Alcoholic Beverages; Food
R1	Used_for Arg1:T1 Arg2:T2	
R2	Has_Age Arg1:T52 Arg2:T53	
R3	Experiences Arg1:T54 Arg2:T10	
T62	Quantifier_or_Qualifier 597 610	primera línea
R4	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T62	
R5	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T62	
R6	Experiences Arg1:T54 Arg2:T11	
R7	Experiences Arg1:T54 Arg2:T45	
R8	Used_for Arg1:T13 Arg2:T10	
R9	Used_for Arg1:T14 Arg2:T10	
R10	Used_for Arg1:T13 Arg2:T11	
R11	Used_for Arg1:T14 Arg2:T11	
R12	Has_Duration_or_Interval Arg1:T14 Arg2:T55	
R13	Has_Duration_or_Interval Arg1:T13 Arg2:T55	
R14	Has_Duration_or_Interval Arg1:T44 Arg2:T55	
R15	Has_Age Arg1:T56 Arg2:T63	
T64	CONC 712 716	EDSS
#56	AnnotatorNotes T64	C3830336; EDSS - Expanded Disability Score; Intellectual Product
T65	Result_or_Value 717 721	?5.5
R16	Has_Result_or_Value Arg1:T64 Arg2:T65	
T66	CONC 742 751	inclusión
#57	AnnotatorNotes T66	C1512693; Inclusion; Qualitative Concept
R17	Overlap Arg1:T64 Arg2:T66	
R18	Experiences Arg1:T56 Arg2:T15	
R19	Causes Arg1:T17 Arg2:T16	
R20	Used_for Arg1:T12 Arg2:T18	
R21	Experiences Arg1:T58 Arg2:T18	
R22	Experiences Arg1:T58 Arg2:T19	
R23	Location_of Arg1:T46 Arg2:T22	
R24	Location_of Arg1:T23 Arg2:T22	
T67	Result_or_Value 1102 1127	> 2.5 del límite superior
R25	Has_Result_or_Value Arg1:T47 Arg2:T67	
R26	Has_Result_or_Value Arg1:T24 Arg2:T67	
R27	Used_for Arg1:T48 Arg2:T26	
R28	Used_for Arg1:T49 Arg2:T26	
R29	Used_for Arg1:T27 Arg2:T26	
R30	Used_for Arg1:T28 Arg2:T26	
R31	Used_for Arg1:T29 Arg2:T26	
R32	Used_for Arg1:T30 Arg2:T26	
R33	Used_for Arg1:T31 Arg2:T26	
R34	Used_for Arg1:T32 Arg2:T26	
R35	Used_for Arg1:T33 Arg2:T26	
R36	Used_for Arg1:T34 Arg2:T26	
R37	Location_of Arg1:T38 Arg2:T37	
R38	Location_of Arg1:T38 Arg2:T39	
R39	Used_for Arg1:T42 Arg2:T41	
T68	Quantifier_or_Qualifier 1425 1431	activa
#58	AnnotatorNotes T68	C0679217; Active State; Idea or Concept
R40	Has_Quantifier_or_Qualifier Arg1:T40 Arg2:T68	
R41	Causes Arg1:T61 Arg2:T43	
R42	Causes Arg1:T57 Arg2:T43	
A5	Experiencer T51 Patient
A6	Experiencer T52 Patient
A7	Experiencer T54 Patient
A8	Experiencer T56 Patient
A9	Experiencer T58 Patient
A10	Assertion T56 Hypothetical
